Mechanistically, enforced Agtr2 expression suppressed fatty acid metabolism – a key driver of AML stemness and growth – and inhibited downstream signaling pathways, including GSK3, PI3K/AKT, and Wnt/β-catenin. The gene discussed is AGTR2; the disease is acute myeloid leukemia.